Chemoinformaics analysis of CIS-DEHYDROMATRICARIA-ESTER
| Molecular Weight | 176.215 | nRot | 2 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 4 |
| Exact Molecular Weight | 176.084 | nRing | 0 |
| Solubility: LogS | -3.084 | nHRing | 0 |
| Solubility: LogP | 3.1 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 27.9755 |
| nHD | 0 | BPOL | 14.6425 |
| QED | 0.362 |
| Synth | 3.343 |
| Natural Product Likeliness | 2.429 |
| NR-PPAR-gamma | 0.8 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.009 |
| Pgp-sub | 0 |
| HIA | 0.057 |
| CACO-2 | -4.082 |
| MDCK | 0.0000396 |
| BBB | 0.018 |
| PPB | 0.993499 |
| VDSS | 1.163 |
| FU | 0.0183445 |
| CYP1A2-inh | 0.984 |
| CYP1A2-sub | 0.722 |
| CYP2c19-inh | 0.953 |
| CYP2c19-sub | 0.788 |
| CYP2c9-inh | 0.913 |
| CYP2c9-sub | 0.891 |
| CYP2d6-inh | 0.758 |
| CYP2d6-sub | 0.252 |
| CYP3a4-inh | 0.845 |
| CYP3a4-sub | 0.21 |
| CL | 8.072 |
| T12 | 0.639 |
| hERG | 0.014 |
| Ames | 0.614 |
| ROA | 0.784 |
| SkinSen | 0.961 |
| Carcinogencity | 0.726 |
| EI | 0.94 |
| Respiratory | 0.932 |
| NR-Aromatase | 0.835 |
| Antiviral | No |
| Prediction | 0.778086 |